Ologen in primary congenital glaucoma

A Comparative Study; The Use of Collagen Implant Versus Mitomycin-C in Combined Trabeculotomy And Trabeculectomy For Treatment of Primary Congenital Glaucoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201703002113756

Enrollment

Registered

2017-03-18

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases Paediatrics Congenital glaucoma

Interventions

Ologen implantation

Mitomycin C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age less than three years primary congenital glaucoma History of lacrimation, photophobia, blepharospasm and or eye enlargement Signs of elevated IOP, increased corneal diameters, corneal haze and or increased cup-to- disc ratio.

Exclusion criteria

Exclusion criteria: Secondary glaucoma Patients with other ocular pathology, e.g. congenital cataract, Patients with previous ocular surgery including glaucoma surgery Patients who could not adhere to the follow up schedule

Design outcomes

Primary

Measure	Time frame
Intraocular pressure	—

Secondary

Measure	Time frame
Transverse corneal diameter	—

Countries

Egypt

Contacts

Public ContactMohammed Iqbal Saleem

Assistant professor

dr_m_iqbal@yahoo.com+20168559840

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026